Skip to main content
OSCR logo

OSCR · Oscar Health, Inc. · Earnings Call Transcripts & Audio

Track OSCR — free
$30.84 +1.07 (+3.59%) At close · Sep 30
Market Cap
$9.14B
Shares
308.64M
Volume · Sep 30 5.45M Avg daily vol (3M) 5.31M

Oscar Health, Inc. Earnings Call Transcripts

Quarterly earnings calls for Oscar Health, Inc. (OSCR), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-06
Oscar Health, Inc. (OSCR) Q2 2026 Earnings Call Transcript
Confident tone Record profitability and financial performance Product innovation and member navigation Operating leverage and cost discipline
Revenue
$4.88B
▲ 70.4% YoY
Diluted EPS
$1.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Oscar Health, Inc. (OSCR) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript
Confident tone Risk adjustment and metal mix Individual market dynamics Q1 financial performance
Revenue
$4.65B
▲ 52.6% YoY
Diluted EPS
$2.07
▲ 125% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call Transcript
Confident tone ICRA and defined contribution strategy Membership growth and market share MLR and market morbidity
Revenue
$2.81B*
▲ 17.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Oscar Health, Inc. (OSCR) Q3 2025 Earnings Call Transcript
Positive tone 2025 Financial Results and 2026 Profitability Outlook Higher Market Morbidity and Risk Adjustment Membership Growth and Geographic Expansion
Revenue
$2.99B
▲ 23.2% YoY
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Oscar Health, Inc. (OSCR) Q2 2025 Earnings Call Transcript
Balanced tone 2025 financial results and guidance ICHRA growth strategy and acquisitions Market morbidity shift
Revenue
$2.86B
▲ 29% YoY
Diluted EPS
$-0.89
▼ 545% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call Transcript
Confident tone Medical loss ratio and risk adjustment Top-line growth and membership SG&A efficiency
Revenue
$3.05B
▲ 42.2% YoY
Diluted EPS
$0.92
▲ 48.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-04
Oscar Health, Inc. (OSCR) Q4 2024 Earnings Call Transcript
Confident tone Medical loss ratio and pricing discipline Record financial performance and profitability milestones Above-market growth in individual ACA market
Revenue
$2.39B*
▲ 67.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Oscar Health, Inc. (OSCR) Q3 2024 Earnings Call Transcript
Confident tone Medical Loss Ratio (MLR) and utilization 2025 open enrollment / ACA market growth SG&A leverage and operating efficiency
Revenue
$2.42B
▲ 68.3% YoY
Diluted EPS
$-0.22
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Oscar Health, Inc. (OSCR) Q2 2024 Earnings Call Transcript
Confident tone Medical loss ratio / medical costs 2025 and rate filings ACA / enhanced subsidies
Revenue
$2.22B
▲ 45.9% YoY
Diluted EPS
$0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Oscar Health, Inc. (OSCR) Q1 2024 Earnings Call Transcript
Confident tone Medical Loss Ratio Membership Growth Profitability and Net Income Milestone
Revenue
$2.14B
▲ 45.8% YoY
Diluted EPS
$0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-07
Oscar Health, Inc. (OSCR) Q4 2023 Earnings Call Transcript
Confident tone Open enrollment and membership growth Medical loss ratio improvement Member experience and NPS
Revenue
$1.43B*
▲ 43.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Oscar Health, Inc. (OSCR) Q3 2023 Earnings Call Transcript
Revenue
$1.44B
▲ 47.2% YoY
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Oscar Health, Inc. (OSCR) Q2 2023 Earnings Call Transcript
Revenue
$1.52B
▲ 49.6% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Oscar Health, Inc. (OSCR) Q1 2023 Earnings Call Transcript
Revenue
$1.47B
▲ 51.1% YoY
Diluted EPS
$-0.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Oscar Health, Inc. (OSCR) Q4 2022 Earnings Call Transcript
Revenue
$995.13M*
▲ 100.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Oscar Health, Inc. (OSCR) Q3 2022 Earnings Call Transcript
Revenue
$978.43M
▲ 120.4% YoY
Diluted EPS
$-0.91
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Oscar Health, Inc. (OSCR) Q2 2022 Earnings Call Transcript
Revenue
$1.02B
▲ 92.2% YoY
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Oscar Health, Inc. (OSCR) Q1 2022 Earnings Call Transcript
Revenue
$972.76M
▲ 163.3% YoY
Diluted EPS
$-0.36
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Oscar Health, Inc. (OSCR) Q4 2021 Earnings Call Transcript
Revenue
$496.07M*
▲ 214.6% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Oscar Health, Inc. (OSCR) Q3 2021 Earnings Call Transcript
Revenue
$443.98M
▲ 336.6% YoY
Diluted EPS
$-1.02
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Oscar Health, Inc. (OSCR) Q2 2021 Earnings Call Transcript
Revenue
$529.28M
▲ 358.9% YoY
Diluted EPS
$-0.35
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Oscar Health, Inc. (OSCR) Q1 2021 Earnings Call Transcript
Revenue
$369.39M
▲ 319.3% YoY
Diluted EPS
$-1.00
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 1568651 CUSIP 687793109 13F (30d) 11 filings 9 filers Visit website Investor relations